{
    "2018-05-17": [
        [
            {
                "time": "",
                "original_text": "华兰生物：四价流感疫苗若顺利获批，将积极影响今年经营业绩",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "四价流感疫苗",
                        "获批",
                        "经营业绩"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018",
                "original_text": "四价流感疫苗注册推进 预计于2018年上市",
                "features": {
                    "keywords": [
                        "四价流感疫苗",
                        "注册推进",
                        "2018年上市"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "融资资金持续加仓 医药行情加速扩散",
                "features": {
                    "keywords": [
                        "融资资金",
                        "加仓",
                        "医药行情",
                        "加速扩散"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "48股获券商买入评级 滨化股份目标涨幅达105.48%",
                "features": {
                    "keywords": [
                        "券商买入评级",
                        "滨化股份",
                        "目标涨幅",
                        "105.48%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "化工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}